News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
538,649 Results
Type
Article (33878)
Company Profile (161)
Press Release (504610)
Section
Business (155026)
Career Advice (740)
Deals (25277)
Drug Delivery (69)
Drug Development (59698)
Employer Resources (79)
FDA (14260)
Job Trends (11893)
News (259694)
Policy (24155)
Tag
2024 BioCapital Digital (2)
2024 BioForest Digital (8)
2024 BioForest Standard (1)
2024 BioMidwest Digital (3)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (6)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (11)
2024 Biotech Beach Digital (6)
2024 Biotech Beach Standard (3)
2024 Genetown Digital (1)
2024 Genetown Standard (7)
2024 Lone Star Bio Digital (5)
2024 Pharm Country Digital (4)
2024 Pharm Country Standard (3)
2025 Lone Star Bio Digital (4)
2026 BioCapital Elite (1)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Pharm Country Elite (1)
2026 Pharm Country Standard (1)
Academia (2300)
Accelerated approval (3)
Adcomms (8)
Allergies (80)
Alliances (43469)
ALS (62)
Alzheimer's disease (1021)
Antibody-drug conjugate (ADC) (84)
Approvals (14301)
Artificial intelligence (245)
Autoimmune disease (10)
Automation (11)
Bankruptcy (211)
Best Places to Work (9748)
BIOSECURE Act (9)
Biosimilars (42)
Biotechnology (118)
Bladder cancer (48)
Brain cancer (21)
Breast cancer (205)
Cancer (1611)
Cardiovascular disease (127)
Career advice (661)
Career pathing (17)
CAR-T (123)
Cell therapy (328)
Cervical cancer (19)
Clinical research (48926)
Collaboration (690)
Compensation (192)
Complete response letters (11)
COVID-19 (2002)
CRISPR (36)
C-suite (185)
Cystic fibrosis (72)
Data (1654)
Decentralized trials (2)
Denatured (25)
Depression (32)
Diabetes (193)
Diagnostics (5809)
Digital health (16)
Diversity (7)
Diversity, equity & inclusion (17)
Drug discovery (96)
Drug pricing (61)
Drug shortages (23)
Duchenne muscular dystrophy (56)
Earnings (54761)
Editorial (19)
Employer branding (12)
Employer resources (70)
Events (76647)
Executive appointments (544)
FDA (15281)
Featured Employer (35)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (3)
Frontotemporal dementia (3)
Funding (571)
Gene editing (90)
Generative AI (24)
Gene therapy (215)
GLP-1 (502)
Government (3440)
Grass and pollen (4)
Guidances (41)
Healthcare (15570)
Huntington's disease (11)
IgA nephropathy (19)
Immunology and inflammation (49)
Indications (21)
Infectious disease (2104)
Inflammatory bowel disease (102)
Inflation Reduction Act (5)
Influenza (41)
Intellectual property (72)
Interviews (77)
IPO (10929)
IRA (23)
Job creations (2562)
Job search strategy (595)
Kidney cancer (7)
Labor market (14)
Layoffs (243)
Leadership (5)
Legal (4954)
Liver cancer (59)
Lung cancer (243)
Lymphoma (102)
Machine learning (3)
Management (29)
Manufacturing (198)
MASH (50)
Medical device (14005)
Medtech (14010)
Mergers & acquisitions (14739)
Metabolic disorders (478)
Multiple sclerosis (56)
NASH (12)
Neurodegenerative disease (58)
Neuropsychiatric disorders (11)
Neuroscience (1385)
NextGen: Class of 2025 (5401)
Non-profit (3402)
Northern California (1743)
Now hiring (19)
Obesity (239)
Opinion (122)
Ovarian cancer (61)
Pain (73)
Pancreatic cancer (61)
Parkinson's disease (105)
Partnered (15)
Patents (167)
Patient recruitment (84)
Peanut (47)
People (47427)
Pharmaceutical (32)
Pharmacy benefit managers (11)
Phase I (15132)
Phase II (21381)
Phase III (16509)
Pipeline (799)
Podcasts (52)
Policy (66)
Postmarket research (1808)
Preclinical (5889)
Press Release (67)
Prostate cancer (77)
Psychedelics (18)
Radiopharmaceuticals (213)
Rare diseases (240)
Real estate (4619)
Recruiting (30)
Regulatory (17346)
Reports (18)
Research institute (2080)
Resumes & cover letters (100)
Rett syndrome (4)
RNA editing (2)
RSV (29)
Schizophrenia (50)
Series A (98)
Series B (63)
Service/supplier (8)
Sickle cell disease (31)
Southern California (1592)
Special edition (4)
Spinal muscular atrophy (117)
Sponsored (21)
Startups (3205)
State (2)
Stomach cancer (9)
Supply chain (43)
Tariffs (3)
The Weekly (26)
United States (16375)
Vaccines (511)
Venture capitalists (25)
Webinars (10)
Weight loss (156)
Women's health (24)
Worklife (6)
Date
Today (67)
Last 7 days (498)
Last 30 days (2036)
Last 365 days (26253)
2025 (6403)
2024 (27757)
2023 (31919)
2022 (42314)
2021 (45758)
2020 (44559)
2019 (39090)
2018 (29739)
2017 (26811)
2016 (25742)
2015 (30025)
2014 (22809)
2013 (19194)
2012 (20786)
2011 (21282)
2010 (19643)
Location
Africa (517)
Alabama (43)
Alaska (6)
Arizona (170)
Arkansas (13)
Asia (33725)
Australia (5714)
California (4091)
Canada (1560)
China (417)
Colorado (192)
Connecticut (217)
Delaware (111)
Europe (71354)
Florida (674)
Georgia (171)
Idaho (48)
Illinois (413)
India (17)
Indiana (246)
Iowa (5)
Japan (136)
Kansas (99)
Kentucky (15)
Louisiana (5)
Maine (33)
Maryland (724)
Massachusetts (2895)
Michigan (213)
Minnesota (309)
Mississippi (2)
Missouri (70)
Montana (27)
Nebraska (23)
Nevada (36)
New Hampshire (66)
New Jersey (1312)
New Mexico (20)
New York (1206)
North Carolina (747)
North Dakota (8)
Northern California (1743)
Ohio (164)
Oklahoma (11)
Oregon (30)
Pennsylvania (933)
Puerto Rico (9)
Rhode Island (26)
South America (770)
South Carolina (19)
South Dakota (1)
Southern California (1592)
Tennessee (79)
Texas (643)
Utah (147)
Virginia (93)
Washington D.C. (39)
Washington State (414)
West Virginia (3)
Wisconsin (48)
538,649 Results for "magnolia medical technologies".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
BioForest
Magnolia Medical Technologies Marks World AMR Awareness Week by Recognizing the Need to Reduce Antibiotic Usage through Accurate Blood Culture Results
In observance of World AMR Awareness Week (WAAW), Magnolia Medical Technologies, Inc., the inventors of the Steripath® Initial Specimen Diversion Device® (ISDD®) and the ISDD market to prevent false-positive sepsis tests, is driving efforts to highlight the role of diagnostic stewardship in combating the risk of AMR.
November 20, 2023
·
6 min read
BioForest
In Recognition of Sepsis Awareness Month, Magnolia Medical Intensifies Efforts to Combat the Clinical and Economic Risks of Sepsis Misdiagnosis
Magnolia Medical Technologies, Inc., the inventors of the Steripath® Initial Specimen Diversion Device® and the ISDD market, is intensifying efforts to combat sepsis misdiagnosis this Sepsis Awareness Month.
September 7, 2023
·
7 min read
Biotech Beach
USPTO Rejects Patent Claims Asserted by Magnolia Medical, Inc. against Kurin, Inc.
Kurin, Inc., the inventor and manufacturer of the Kurin® blood culture collection sets, announced that the US Patent and Trademark Office has rejected the relevant claims of the ‘483 patent that Magnolia Medical asserted against Kurin.
August 15, 2023
·
1 min read
Biotech Beach
Delaware Federal Court Issues a Stay Order in Patent Dispute between Magnolia Medical and Kurin, Inc.
Kurin, Inc., the inventor and manufacturer of the Kurin® blood culture collection sets, provided an update on the ongoing patent infringement case brought against Kurin by Magnolia Medical.
August 10, 2023
·
2 min read
Policy
Magnolia Medical Technologies Files for Permanent Injunction Against Infringing Kurin Lock Products
Magnolia Medical Technologies, Inc. (“Magnolia Medical”) today announced it filed a motion for permanent injunction in the U.S. District Court for the District of Delaware on September 9, 2022, that would prohibit Kurin, Inc. (“Kurin”) from the continued sale of the infringing Kurin Lock products.
September 13, 2022
·
4 min read
Policy
Magnolia Medical Technologies Wins Patent-Infringement Lawsuit against Kurin, Inc.
A jury for the U.S. District Court of Delaware delivered two unanimous verdicts this week in favor of Magnolia Medical Technologies, Inc. (“Magnolia Medical”) in a lawsuit against Kurin, Inc., (“Kurin”) regarding the unlawful use of its innovative Initial Specimen Diversion Device® (ISDD®) technology.
July 29, 2022
·
3 min read
Policy
USPTO Agrees to Kurin’s Request to Review Validity of Magnolia Medical’s ‘483 Patent
Kurin, Inc. announced that the US Patent and Trademark Office has granted Kurin’s Ex Parte request to reexamine the validity of U.S. Patent No. 10,039,483 that is asserted by Magnolia Medical in ongoing patent litigation.
May 3, 2023
·
2 min read
BioForest
Magnolia Medical Expands Steripath® Micro Initial Specimen Diversion Device® (ISDD®) Product Family with New FDA 510(k) Clearance
Magnolia Medical Technologies, Inc., announced today U.S. Food and Drug Administration (FDA) 510(k) clearance of 19 new Steripath® Micro configurations within the company’s ISDD® product portfolio.
April 11, 2023
·
6 min read
Press Releases
Helius Medical Technologies, Inc. Announces the Establishment of a Wholly Owned Brain Computer Interface (“BCI”) Technology Private Subsidiary
March 13, 2025
·
5 min read
Press Releases
Baird Medical Secures Indonesian Regulatory Approval for Microwave Ablation Technology
March 10, 2025
·
5 min read
1 of 53,865
Next
